中文文獻:
1. 陳應禮(1999),《臺灣講古》,自印 ,1999
2. 韋海浪(2005), “海洛因成癮者接受美沙酮替代療法之短期戒癮”, 取自 http://ir.ym.edu.tw/ir/bitstream/987654321/2556/1/59310012_abstract.pdf
3. 徐森杰(2005),“香港美沙酮減害計畫年”,取自http://www.lourdes.org.tw/Uploads
4. 林長春(2006),《毒品防治法制之研究,中山大學碩士論文》,頁2、頁259
5. 行政院研考會(2006),《毒品防制政策整體規劃報告(95-97核定版) 》,2006年5月,頁4-7
6. 行政院衛生署(2006),《毒品病患愛滋減害試辦計畫》,頁8, 取自:http://www.cdc.gov.tw/ct.asp?xItem=11244&;ctNode=1885&;mp=1
7. 許淑雲(2006), 《靜脈注射藥癮者對減害計畫需求評估~以台中監獄、雲林及嘉義戒治所為例》, 亞洲大學碩士論文
8. 黃營彬、汪志堅(2006),《研究方法》,華泰文化事業公司,頁251
9. 李思賢(2006)。”藥癮再犯罪成因與心理治療介入的可行性:出監毒癮者之回溯性與前瞻性追蹤研究”。公共衛生學會聯合年會:暴力與傷害預防大會。
10. 法務部矯正司(2007),”矯正司部務會報報告:監獄毒品犯矯正策略之檢視與展望”,2007年11月
11. 陳泉錫(2008),“建立毒品成癮者單一窗口服務-毒品防制政策之策略規劃建議”,《研考雙月刊》,第32卷,第1期,66-76。
12. 陳泉錫、林雪蓉等(2008),《行政院及所屬機關出國報告—澳洲香港減害計畫參訪》 2008.12.3,頁17
URL: http://www.moj.gov.tw/public/Attachment/1101912322771.pdf
13. 陳泉錫、林雪蓉等(2008a):“澳洲藥癮機關組織”。 《行政院及所屬機關出國報告—澳洲香港減害計畫參訪》,2008a; 頁39
14. 法務部矯正司(2009),“建構毒品成癮者之本土戒治模式第一,二,三階段研討會會議紀錄彙整報告” 2009.02.04, 頁3-1、3-2
15. 法務部統計處(2010),“執行毒品案件裁判確定有罪人數”。《法務統計摘要》2010年1月21日,頁12, 表3。
16. 法務部統計處(2010a),“執行毒品案件裁判確定有罪人數即再累犯情形”, 《法務統計摘要》,2010年1月21日,頁12, 表4。
17. 法務部統計處(2010):“地方法院檢察署實施毒品減害計畫成效統計表”(99年檢察長會議報告資料,資料收集期間:99/1-99/10)。台北:法務部統計處。
18. 法務部資訊處(2010),“各縣市毒品危害防治中心強制列管個案統計表” 2010.12 ; 頁6。
19. 楊士隆,李寧(2010),“藥物法庭在台灣實施之可行性研究”,《中國藥物依賴性雜誌》,19(4):290-296
20. 行政院 (2010),“行政院回覆監察院函” 2010年4月29日院臺法字第0990023109號,取自http://www.cy.gov.tw/AP_Home/Upload/eDoc_t02_document/586/98%E5%8F%B8%E6%AD%A34.doc
21. 吳耀宗(2010),“論我國毒品管制之法政策走向從戡亂時期肅清煙毒條例至毒品危害防制條例”,《月旦法學雜誌》(第180期),,522. 詹中原、陳泉錫,“台灣毒品防制政策成效未能彰顯之成因探究” 台灣衛誌 2011, Vol.30, No.6,604-61623. 戴伸峰,曾淑萍,楊士隆(2011), “台灣地區非法藥物濫用高危險群青少年對現行毒品防治政策成效及戒毒成功因素評估之實證研究”,《青少年犯罪防治研究期刊》3卷2期24. 林俊宏(2011),《地方毒品危害防制中心的實際運作-政策網絡的分析》,政大公共行政學位論文,http://nccur.lib.nccu.edu.tw/handle/140.119/51604)25. 行政院研究發展考核委員會(2011),《毒品減害措施之研究》 RDEC-RES-099-025,2011.8.
26. 行政院研究發展考核委員會(2009):《毒品防制政策整體規劃報告(RDEC-RES-097-001)》,http://www.rdec.gov.tw/public/PlanAttach/200906061627208001812.pdf。
27. 法務部統計處(2012),“執行毒品案件裁判確定有罪人數”。《法務統計摘要》,2012年1月,頁3。
28. MBA智庫百科, 取自 http://wiki.mbalib.com/zh-tw/%E7%AD%96%E7%95%A5%E6%96%B9%E6%A0%BC%E6%A8%A1%E5%9E%8B
英文文獻:
1. Albert L. Lederer and Vijay Sethi (1988), “The Implementation of Strategic Information Systems Planning Methodologies”, MIS Quarterly; 12( 3): 445-461, URL: http://www.jstor.org/stable/249212
2. Albert Sargent,Jr. (2006) “Outsourcing Relationship Literature: An Examination and Implication for Future Research”, ACM SIGMIS-CPR Apr.2006
3. Ritter A., Cameron J. (2005), “A systematic review of harm reduction”, Drug Policy Modelling Projectmonograph 06,Turning Point Alcohol and Drug Centre. pp.3
4. Ball and Ross (1991), The effectiveness of methodone maintenance treatment: patient programmes, service, and outcomes. New York: Springer-Verlag. 1991; pp.160-176
5. Benjamin B.M. Shao, Julie Smith David, (2007). “The impact of offshore outsourcing on IT worker in developed countries” Communication of the ACM, 50(2): 89.
6. Bin Jiang & Amer Qureshi (2006) “Research on outsourcing results: current literature and future opportunities”,Management Decision. London: 2006; 44(1): 44-55.
7. Booth RE, Crowley T, Zhang Y. (1996), “Substance abuse treatment entry, retention, and efectiveness: out-of-treatment opiate injection drug users”.Drug Alcohol Depend 1996; 42:11–20.
8. Bowen GA. “Grounded theory and sensitizing concepts”. Int J Qual Meth 2006; 5:1-9.
9. Bowman、Davis 及Wetherbe http://www.cs.nchu.edu.tw/~fileman/notepad/sa01.htm
10. Drug Court of New South Wales (2010), Drug Court Program http://www.lawlink.nsw.gov.au/lawlink/drug_court/ll_drugcourt.nsf/pages/adrgcrt_program, last accessed: Dec. 12, 2010
11. David S. Metzger, et al. (1993), “Human Immunodeficiency Virus Seroconversion Among Intravenous Drug Users In- and Out-of-Treatment: An 18-Month Prospective Follow-Up”, Journal of Acquired Immune Deficiency Syndromes; 6(9) :969-976.
12. David S. Metzger and Helen Navaline (2003),“Human Immunodeficiency Virus Prevention and the Potential of Drug Abuse Treatment”,Clinical Infectious Diseases;37:451–456
13. David Wellbourne-Wood (1999),“Harm reduction in Australia: some problems putting policy into practice”,International Journal of Drug Policy;10:403–413
14. Debbie Tesch & Timothy J Kloppenborg & Mark N Frolick (2007),“It Project Risk Factors: The Project Management Professionals Perspective”, The Journal of Computer Information Systems. 47(4): 61-69.
15. Debdas Ganguly (2007),“Strategic Fit Of Mis Plan With Organisation Culture – A Milestone In Organisatioal Success” Vidyasagar University Journal of Commerce; 12:80-84
16. Deflem Mathieu (2006). Sociological Theory and Criminological Research: Views from Europe and the United States. Elsevier. 2006, pp. 279. ISBN 0-7623-1322-6.
17. De Leon, G. (1989),“Psychopathology and substance abuse: What is being learnedfrom research in therapeutic communities”. Journal of Psychoactive Drugs; 21:177-188
18. Haden, Mark (2004), “Regulation of Illegal Drugs: An Exploration of Public Health Tools.” International Journal of Drug Policy; 15(4): 225- 230.
19. Hendree E. Jones. (2004),“Practical Considerations for the Clinical Use of Buprenorphine”, Science&; Practice perspectives; 2(2):4–20.
20. Jo Kimber et al (2010). Harm reduction: evidence, impacts and challenges EMCDDA MONOGRAPHS 2010, pp.116
21. Joseph E. Schumacher, Gabriele Fischer, Han-Zhu Qian (2007),“Policy drives harm reduction for drug abuse and HIV/AIDS prevention in some developing countries¬_ CPDD News and views’, Drug and Alcohol Dependence;91: 300–305
22. Kerlinger F, Lee HB (1999), Foundation of Behavioral Research. U.S: Wadsworth Publishing; pp.588.
23. Kintz P., Marquet, P. ((2002), Buprenorphine Therapy of Opiate Addiction, Humana Press, Totowa, NJ. pp.148
24. Kreek, M.J. (1991), “Using methadone effectively: achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs”, NIDA Research Monograph 106, pp. 245–266.
25. McFarlan, McKenny, Cash, Applegate (1992),Corporate information strategy and management: Text and Cases, 3rd Edition Irwin, pp.628
26. Midford R, Acres J, Lenton S, Loxley W, Boots K. (2002), “Cops,drugs and the community: establishing consultative harm reduction structures in two Western Australian locations” International Journal of Drug Policy ,2002; 13: 181-8
27. NIDA, (1991),“Treatment Outcomes for Drug Abuse Clients” U.S. Department of Health and Humanservices, Research Monograph 106, pp. 93.
28. Padgett DK. (1998), Qualitative Methods in Social Work Research: Challenges and Rewards. California: SAGE Publication, 1998; pp.126.
29. Ralph H. Sprague, Jr. Barbara C. McNurlin (1993), Information Systems Management in Practice, pp.255
30. Richard P Mattick, Courtney Breen (2009), “Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence” Published Online: 8 JUL 2009, Assessed: 18 FEB. 2009, http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002209.pub2/abstract
31. Richard Midford , John Acres, Simon Lenton, Wendy Loxley, Kevin Boots (2002),“Cops, drugs and the community: establishing consultative harmreduction structures in two Western Australian locations”, International Journal of Drug Policy; 13 : 181-188
32. Ritter, A. &; Cameron, J. (2005). “A systematic review of harm reduction. Monograph No. 06, DPMP Monograph Series. Fitzroy:Turning Point Alcohol and Drug Centre; pp.3
33. Robert Klepper, Wendell Jones (1998), Outsourcing Information Technology, System &; Services , Prentice Hall p.79,
34. Roy W. Pickens, Carl G. Leukefeld, D.S.W.,Charles R. Schuster (1991), “Overview of Treatment Issues”, U.S. Department Of Health And Humanservices, Research Monograph 106; pp.1-19.
35. Schumacher JE, Fischer G, Qian HZ (2007), “Policy drives harm reduction for drug abuse and HIV/AIDS prevention in some developing countries.” Drug Alcohol Depend; 91: 300-304.
36. Simpson DD, Sells SB (1982), “Effectiveness of treatment for drug abuse: an overview of the DARP research program”. Advances in Alcohol and Substance Abuse; 2(1):7-29.
37. Stitzer, Maxine L., Iguchi, Martin Y., Felch, Linda J. (1992), “Contingent take-home incentive: Effects on drug use of methadone maintenance patients”, Journal of Consulting and Clinical Psychology, 60(6): 927-934
38. Strauss AL. (1987). Qualitative Analysis for Social Scientists. London: Cambridge University Press
39. Tims FM, Fletcher BW, Hubbard RL. (1991), “Treatment Outcomes for Drug Abuse Clients” NIDA, Research Monograph 106; pp.93-113.
40. Tim Rhodes and Dagmar hedrich (2010), EMCDDA MONOGRAPHS 2010 “Harm Reduction: Evidence, impacts and challenges”, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Available at: http://europa.eu pp.48
41. Wellbourne-Wood D. (1999), “Harm reduction in Australia: some problems putting policy into practice”. International Journal of Drug Policy; 10: 403-415
42. Wikipedia (2011), Accessed May. 2011 http://en.wikipedia.org/wiki/Proof_of_concept#cite_ref-2
43. World Health Organization(WHO) Western Pacific Region (2006), “Integration of Harm Reduction Into Abstinence-Based Therapeutic Communities—A case Study of We Help Ourselves ,Australia”, WHO Library Cataloguing in Publication Data